ALDEYRA THERAPEUTICS INC (ALDX)
US01438T1060 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 15.41M | 128.51M | 135.20M | 100.40M | 23.50M | |||
| Cash Equivalents | 52.71M | 14.31M | 9.30M | 129.40M | 54.40M | |||
| Marketable Securities | 44.62M | 0.00 | 29.90M | 0.00 | N/A | |||
| Other Current Assets | 3.98M | 4.99M | 6.70M | 3.00M | 5.20M | |||
| Total Current Assets | 116.72M | 147.81M | 181.00M | 232.80M | 83.10M | |||
| Non-Current Assets | ||||||||
| PPE Net | 331.33K | 516.58K | 300.00K | 400.00K | 300.00K | |||
| Other Non-Current Assets | 267.26K | N/A | N/A | N/A | N/A | |||
| Total Non-Current Assets | 598.59K | 516.58K | 300.00K | 300.00K | 300.00K | |||
| TOTAL ASSETS | 117.32M | 148.33M | 181.30M | 233.10M | 83.40M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 279.96K | 15.15M | 900.00K | 0.00 | 3.70M | |||
| Accrued Expenses | 10.69M | 5.78M | 14.30M | 10.80M | 8.40M | |||
| Accounts Payable | 186.92K | 1.34M | 100.00K | 1.00M | 400.00K | |||
| Other Current Liabilities | 6.00M | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 17.15M | 22.26M | 15.40M | 11.80M | 12.40M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 15.00M | 0.00 | 14.90M | 15.50M | 11.40M | |||
| Other Non-Current Liabilities | 70.23K | 6.27M | 0.00 | 100.00K | N/A | |||
| Total Non-Current Liabilities | 15.07M | 6.27M | 14.90M | 15.60M | 11.40M | |||
| TOTAL LIABILITIES | 32.22M | 28.53M | 30.30M | 27.40M | 23.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -434.30M | -394.26M | -356.70M | -294.70M | -236.90M | |||
| Additional Paid In Capital | 519.27M | 513.99M | 507.80M | 500.40M | 296.40M | |||
| Common Shares | 59.55K | 59.20K | 100.00K | 100.00K | 0.00 | |||
| Other Shareholders' Equity | 66.54K | 0.00 | -100.00K | 0.00 | 0.00 | |||
| Shares Outstanding | 59.55M | 59.20M | 58.60M | 58.10M | 38.70M | |||
| Tangible Book Value per Share | 1.43 | 2.02 | 2.58 | 3.54 | 1.54 | |||
| Total Shareholders' Equity | 85.10M | 119.80M | 151.00M | 205.70M | 59.50M | |||
| TOTAL LIABILITIES AND EQUITY | 117.32M | 148.33M | 181.30M | 233.10M | 83.40M | |||
| Statistics | ||||||||
| Debt/Equity | 0.18 | N/A | 0.10 | 0.08 | 0.19 | |||
| Current Ratio | 6.80 | 6.64 | 11.75 | 19.73 | 6.70 | |||
| Return On Assets (ROA) | -38.18% | -25.31% | -34.21% | -24.79% | -45.02% | |||
| Return On Equity (ROE) | -52.64% | -31.34% | -41.07% | -28.09% | -63.11% | |||
All data in USD , ROIC based on taxRate of 0.21